Legend Strategy International Holdings Group Company Limited has entered into a sale and purchase agreement to acquire shares in Auro Hong Kong Limited. Following completion of the acquisition, the Group will have the right to nominate and replace up to two directors on the five-member board of Beisheng Biotechnology (Shenzhen) Co., Ltd., a subsidiary involved in the transaction. The company’s board considers the terms of the acquisition to be fair and reasonable.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Strategy International Holdings Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251223-11965613), on December 23, 2025, and is solely responsible for the information contained therein.